导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.57% | 533/1050 |
| 近一周 | -1.73% | 299/1104 |
| 近一月 | -0.56% | 116/1102 |
| 近一季 | 0.21% | 247/1092 |
| 近半年 | -5.66% | 638/1070 |
| 近一年 | 7.93% | 392/1018 |
| 近两年 | 56.64% | 454/926 |
| 近三年 | 42.89% | 305/834 |
| 成立以来 | 50.10% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.78% 358/1070 |
-6.98% 841/1101 |
- - |
- - |
| 2025 | 29.17% 485/1065 |
5.69% 361/1014 |
3.47% 396/1038 |
14.60% 748/1050 |
3.07% 237/1065 |
| 2024 | 12.26% 234/1011 |
1.13% 255/960 |
1.93% 200/983 |
9.79% 633/991 |
-0.82% 369/1011 |
| 2023 | -5.91% 221/952 |
5.81% 266/880 |
4.21% 48/895 |
-13.01% 726/915 |
-1.92% 224/952 |
| 2022 | -11.72% 109/867 |
-16.60% 340/773 |
10.05% 266/806 |
-5.41% 72/845 |
1.67% 343/867 |
| 2021 | 26.52% 96/740 |
-12.34% 530/580 |
24.94% 93/659 |
4.35% 134/704 |
10.70% 63/740 |
| 2020 | 40.64% 297/554 |
-2.59% 227/419 |
21.25% 265/466 |
6.44% 334/517 |
11.86% 298/554 |
| 2019 | 36.02% 255/410 |
28.57% 451/1146 |
-5.15% 719/1228 |
5.09% 198/390 |
6.14% 304/410 |
| 2018 | -28.87% 201/349 |
- - |
-8.14% 354/990 |
-7.41% 616/1000 |
-16.00% 910/1080 |
| 2017 | 15.08% 103/285 |
- - |
- - |
- - |
- - |
| 2016 | -20.59% 119/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 华泰柏瑞积极优选股票A VS. 东吴新产业精选股票A(580008) |